Future Therapeutic Directions for the Treatment of PsoriasisCitation formats

Standard

Future Therapeutic Directions for the Treatment of Psoriasis. / Warren, R. B.; Griffiths, C. E M.

In: Actas Dermo-Sifiliograficas, Vol. 100, No. 2, 12.2009, p. 28-31.

Research output: Contribution to journal › Article › peer-review

Harvard

Warren, RB & Griffiths, CEM 2009, 'Future Therapeutic Directions for the Treatment of Psoriasis', Actas Dermo-Sifiliograficas, vol. 100, no. 2, pp. 28-31. https://doi.org/10.1016/S0001-7310(09)73375-7

APA

Warren, R. B., & Griffiths, C. E. M. (2009). Future Therapeutic Directions for the Treatment of Psoriasis. Actas Dermo-Sifiliograficas, 100(2), 28-31. https://doi.org/10.1016/S0001-7310(09)73375-7

Vancouver

Warren RB, Griffiths CEM. Future Therapeutic Directions for the Treatment of Psoriasis. Actas Dermo-Sifiliograficas. 2009 Dec;100(2):28-31. https://doi.org/10.1016/S0001-7310(09)73375-7

Author

Warren, R. B. ; Griffiths, C. E M. / Future Therapeutic Directions for the Treatment of Psoriasis. In: Actas Dermo-Sifiliograficas. 2009 ; Vol. 100, No. 2. pp. 28-31.

Bibtex

@article{cf0fd566f8db46358ddd9855374ba214,
title = "Future Therapeutic Directions for the Treatment of Psoriasis",
abstract = "The future management of psoriasis will depend on a number of distinct but ultimately inter-related strands of evidence, these are: (i) the interplay of genes and environment and the characterisation of psoriasis phenotypes; (ii) the role of pharmacogenetics in personalised healthcare; (iii) the translation of basic scientific discovery of relevant immune and angiogenic pathways into targeted biologic and small molecule therapies; and (iv) the recognition that the management of any chronic disease is enhanced by an understanding of psychosocial issues. A reductionist approach to development of new therapies will be paramount but serendipity and the prepared mind will contribute, as they have always done. {\textcopyright} 2009 Academia Espa{\~n}ola de Dermatolog{\'i}a y Venereolog{\'i}a.",
keywords = "biologic therapy, biologics, personalised medicine, pharmacogenetics, phenotypes, psoriasis",
author = "Warren, {R. B.} and Griffiths, {C. E M}",
year = "2009",
month = dec,
doi = "10.1016/S0001-7310(09)73375-7",
language = "English",
volume = "100",
pages = "28--31",
journal = "Actas Dermo-Sifiliograficas",
issn = "0001-7310",
publisher = "Ediciones Doyma",
number = "2",

}

RIS

TY - JOUR

T1 - Future Therapeutic Directions for the Treatment of Psoriasis

AU - Warren, R. B.

AU - Griffiths, C. E M

PY - 2009/12

Y1 - 2009/12

N2 - The future management of psoriasis will depend on a number of distinct but ultimately inter-related strands of evidence, these are: (i) the interplay of genes and environment and the characterisation of psoriasis phenotypes; (ii) the role of pharmacogenetics in personalised healthcare; (iii) the translation of basic scientific discovery of relevant immune and angiogenic pathways into targeted biologic and small molecule therapies; and (iv) the recognition that the management of any chronic disease is enhanced by an understanding of psychosocial issues. A reductionist approach to development of new therapies will be paramount but serendipity and the prepared mind will contribute, as they have always done. © 2009 Academia Española de Dermatología y Venereología.

AB - The future management of psoriasis will depend on a number of distinct but ultimately inter-related strands of evidence, these are: (i) the interplay of genes and environment and the characterisation of psoriasis phenotypes; (ii) the role of pharmacogenetics in personalised healthcare; (iii) the translation of basic scientific discovery of relevant immune and angiogenic pathways into targeted biologic and small molecule therapies; and (iv) the recognition that the management of any chronic disease is enhanced by an understanding of psychosocial issues. A reductionist approach to development of new therapies will be paramount but serendipity and the prepared mind will contribute, as they have always done. © 2009 Academia Española de Dermatología y Venereología.

KW - biologic therapy

KW - biologics

KW - personalised medicine

KW - pharmacogenetics

KW - phenotypes

KW - psoriasis

U2 - 10.1016/S0001-7310(09)73375-7

DO - 10.1016/S0001-7310(09)73375-7

M3 - Article

C2 - 20096159

VL - 100

SP - 28

EP - 31

JO - Actas Dermo-Sifiliograficas

JF - Actas Dermo-Sifiliograficas

SN - 0001-7310

IS - 2

ER -